Clinical Trial Update: TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years [NA]

View source ↗

Summary

Clinical trial update for a thrombopoietin receptor agonist (TPO-RA) in immune thrombocytopenia in patients aged 14 years and older; the study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Thrombopoietin receptor agonist (thrombopoietin receptor agonist)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Primary Immune Thrombocytopenic Purpura | NA | Status: RECRUITING